We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,
Australasia,Asia,Middle East,Africa
Monthly Production Capacity: hundreds of grams
Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag
Delivery Lead Time: In stock or 2-3weeks
Sample Provided: yes
Payment Terms: T/T
LL-37 is a multifunctional antimicrobial peptide, which has the potential to be developed into a drug with dual functions of antibacterial and immunity enhancing. LL-37 is the only member of the cathelicidin family, which has been found in human body so far. It is also the only amphiphilic α - helix antibacterial peptide in human body. LL-37 is widely distributed in human blood cells and epithelial cells, and has broad-spectrum antibacterial effect. The antibacterial activity depends on the formation of its spiral conformation, and kills bacteria through the "carpet like" mechanism. LL-37 has the function of neutralizing endotoxin, binding with LPS and CD14, neutralizing the biological activity of LPS, and using formyl peptide receptor like 1 (FPRL1) as receptor-mediated chemotaxis, recruiting immune cells to the infected site and clearing the pathogens. Many infectious diseases are related to low expression or dysfunction of LL-37.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
